Logo for University of Iowa Health Care This logo represents the University of Iowa Health Care

Jennifer Robinson, MD MPH

Contact Information

Faculty Profile

Brief description of current research:

As an active researcher, Dr. Robinson has performed numerous clinical trials sponsored by the National Institutes of Health and the pharmaceutical industry. She was co-principal investigator for the Women’s Health Initiative (WHI) at the University of Iowa as well as principal investigator for the WHI ancillary studies, including the WHI-Mental Status MRI, WHI Study of Cognitive Aging, and the WHI-Coronary Artery Calcium studies.  She has conducted extensive research on a wide range anti-atherosclerotic and metabolic agents, including lipid-modifying, anti-inflammatory, antihypertensive, weight loss, and diabetic treatments as well as postmenopausal hormone therapy.  Dr. Robinson has published numerous articles in the area of lipids-modifying drugs, cardiovascular risk stratification, and cardiovascular prevention.  She has lectured widely on preventive cardiology and the diagnosis and treatment of disorders of lipid metabolism.  She is Vice-Chair for the American Heart Association/American College of Cardiology Cholesterol Guidelines  (formerly known as the National Cholesterol Education Program Adult Treatment Panel IV) and a member of the American Heart Association/American College of Cardiology Risk Reduction Guidelines (formerly known as the National Heart, Lung, and Blood Institute Risk Reduction Working Group).

3 most influential diabetes/obesity/metabolism publications:

  • Stone NJ, Robinson JG, et al.  ACC/AHA 2013 Guidelines for the Treatment of Blood Cholesterol to Reduce the Risk of Atherosclerotic Cardiovascular Disease; November 2013 in press.
  • Robinson JG, Ballantyne CM, Hsueh WA, Rosen JB, Lin J, Shah A, Tomassini JE, Lowe RS, Tershakavec AM. Age, Abdominal Obesity, and Baseline hs-CRP are Associated with LDL-C, non-HDL-C and ApoB Responses to Ezetimibe/Simvastatin and Atorvastatin in Patients with Metabolic Syndrome.  J Clin Lipidol 2013; 7: 292-303
  • Espeland MA, Bryan NR, Goveas JS, Robinson JG, Siddiqui MS, Liu S, Hogan PE, Casanove R, Coker LH, Yaffe K, Masaki K, Rossom R, Resnick SM, for the WHIMS MI2 Study group.  Influence of Type 2 Diabetes Mellitus on Brain Volumes and Changes in Brain Volumes:  Results from the Women’s Health Initiative Magnetic Resonance Imaging Studies. Diabetes Care 2013;36:90-97. (PMID: 22933440
  • Robinson JG, Manson JE, Larson J, Liu Simin, Song Y, Howard BV, Phillips L, Shikany JM, Allison M, Curb JD, Johnson KC, Watts N.  Lack of Association Between 25(OH)D Levels and Incident Type 2 Diabetes in Older Women, Diabetes Care, 2011 Mar;34(3):628-34. Epub 2011 Feb 2. Featured on the www.MDLinx.com site 02-07-2011. PMID: 21289227 [PubMed - in process] PMCID: PMC3041195 [Available on 2012/3/1]